Manish Gupta joins Jagsonpal Pharma as Managing Director; stock adds ~1%

18 Jul 2022 , 10:30 AM

Jagsonpal Pharma Limited announced the appointment of Manish Gupta as the Managing Director of the Company.

Manish has a proven track record of successfully leading and managing businesses all over the world. His most recent position was as CEO and Managing Director of SeQuent Scientific Limited (SeQuent) for 8 years. He previously served as Strides Pharma Science’s CEO – Pharma Business.

Previously, he worked for Wockhardt in a variety of capacities, most recently as the Managing Director of Pinewood Healthcare in Ireland and the CEO of Radiant Research, a CRO in the United States.

Manish will assume charge of Rajpal Singh Kochhar, the founder and current Managing Director of Jagsonpal. Rajpal Singh Kochhar and his family will remain members of the Company’s Promoter Group.

Manish has led SeQuent since 2014, and he has been instrumental in transforming the company from a small startup to a large corporation. From an India-focused company to a global corporation with operations in India, Turkey, Brazil, and the European Union, establishing itself as India’s largest and a “Top 20” global animal health company.

Jagsonpal Pharma is currently trading at Rs358.15 up by 1.04% from its previous closing of Rs354.45 on the BSE. The scrip opened at Rs354.45 and has touched intraday high and low of Rs363.30 and Rs354.45 respectively.